PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24168234-1	2015	OBJECTIVE: The aim of the study is to explore the pharmacokinetic behavior of candesartan solid dispersions prepared by different pharmaceutical interventions using P-gp inhibitor in rabbits to validate the effectiveness of naringin as a pharmaceutical excipient in enhancing the oral delivery of lipophilic candesartan cilexetil.	candesartan	78-89	ATP-dependent translocase ABCB1	Oryctolagus cuniculus	165-169	
24168234-7	2015	CONCLUSION: These results are quite stimulating for further development of a clinically useful oral formulation of candesartan cilexetil based on P-gp inhibition using naringin, a natural flavonoid as a pharmaceutical excipient.	candesartan	115-126	ATP-dependent translocase ABCB1	Oryctolagus cuniculus	146-150